Navigation Links
Helix BioPharma Corp. Announces Positive Phase II Clinical Results,with its Topical Interferon Alpha-2b

Helix BioPharma Corp.

AURORA, ON, March 30, 2007 /PRNewswire-FirstCall/ - Helix today announced positive results from its phase II clinical study of its Topical Interferon Alpha-2b in women with human papilloma virus (HPV) induced low-grade cervical lesions.

The study showed a clinically efficacious response to treatment in nearly half of the treated patients. In addition, the product demonstrated an excellent safety profile, with no significant local intolerance or drug-related serious adverse event observations.

"Treated patients responded well, both in terms of efficacy and safety to this new investigational therapeutic," said Prof. Dr. med. Achim Schneider M.P.H., a world expert in the field of cervical cancer and Director of the Department of Gynaecology at the Charite University Hospital in Berlin. "Helix's product shows real promise as a practical and effective pharmaceutical means of preventing cervical cancer development in women presenting with HPV-induced cervical lesions", continued Prof. Schneider.

About the Clinical Study

A total of 41 women with cytologically confirmed, HPV-induced low-grade squamous intraepithelial lesions (LSIL) of the cervix were studied across four sites in Germany. Twenty women received Topical Interferon Alpha-2b, self-administered intravaginally three times per week for a period of 6 weeks with a follow-up evaluation at 12 weeks, compared with 21 separately studied women who received no treatment whatsoever over the same study period.

The primary endpoint and main outcome for both groups was the Pap-response rate defined as the proportion of patients with resolution of their abnormal Pap smear LSIL cytology to normal during the 12 week study duration. Pap smear normalization was considered to occur if the patient's Pap smear improved to group II or better from any of Pap smear groups IIW through IIID as per the common European stan
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
2. Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy
3. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
4. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
5. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
6. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
7. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
8. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
9. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
10. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
11. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results

Post Your Comments:
(Date:11/24/2009)...AnadysPharmaceuticals,Inc.(Nasdaq: ANDS )announced...ealthcareConferenceonTuesday,December1,2009at9:00a...ewYorkPalaceHotel.SteveWorland,Ph.D.,PresidentandC...ofAnadysanditsclinicaldevelopmentprograms,ANA598an...taneouslywebcastandcanbeaccessedontheInvestorRelat...
(Date:11/24/2009)...iontofamily,friendsandhealth,cancersurvivorDianeWi...ratitudelist. ,, "Theyheardthefactsandmadetheju...dictstotaling$103millionindamagesagainstWyethPharm...widewhohavesuedWyethandPfizerpharmaceuticals,maker...kiandtheothervictimsofhormonetherapyhaveallegedinl...
(Date:11/24/2009)...s,Inc.,aprivately-helddeveloperandmarketeroftheVer...nosticsystemformeasuringanindividual,sresponsetomu...n),announcedtodaythatTimothyI.Still,PresidentandCE...OfficerofAccumetrics,willbepresentingacorporateove...cebeingheldinNewYorkCityonDecember1-2,2009atThePal...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 1Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 2Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 3Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism 56079 4Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 1Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 2Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers 3B 241 Increase Gives State Second Highest Cigarette Tax in the Nation 56075 3ACells CEO to Present at Rodman 26 Renshaws 2009 Annual Global Investment Conference 13808 1ACells CEO to Present at Rodman 26 Renshaws 2009 Annual Global Investment Conference 13808 2
...jective response supports expansion of Simon 2-Sta...RANFORD, Conn., June 11 CuraGen Corporation,(Nasd...mpany focused on,oncology, announced today that it...reatment of patients with unresectable Stage III o...for advancement to the second stage,of enrollment....
...une 10 Biopure Corporation,(Nasdaq: BPUR ) today...hopedic trial (HEM-115) have been published in the...per is entitled "HBOC-201 as an Alternative,to Blo...a Multicenter Phase,III Trial in Elective Orthoped...ull through the complex data,repeatedly until insi...
Other Medicine Technology:CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma 2CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma 3CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma 4Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma 2
(Date:11/24/2009)...ING,Md.,Nov.24/PRNewswire-USNewswire/--Parties,fam...llpartoftheholidaycheer.Butthemerrimentcanchangeto...://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO )...g,diarrhea,andflu-likesymptoms,whichcanstartanywhe...onsumed. ,, "Thegoodnewsisthatpracticingfourbas...
(Date:11/24/2009)...SCO,Nov.24/PRNewswire/--Quantros,aleadinghealthcar...vider,announcedtodaythatithaslicensedintellectualp...tyofMichiganforintegrationintoQuantros,suiteofsafe...iversity,ssoftwarewithintheSRMproductfamilywillena...sthroughutilizationofahealthcareprovider,sintegrat...
(Date:11/24/2009)...h.,Nov.24/PRNewswire/--HealthPlusofMichiganhaslaun...gnedspecificallyforindividuals18to64andtheirfamili...irectly. ,, Thenew HealthPlusSignature plansare...entsandbrokersthroughouttheHealthPlusservicearea.M...vailablebytoll-freephonecallto1-877-562-0907. ,...
(Date:11/24/2009)...lsNewYorkandtheNewYorkStateFraternalOrderofPoliced...iesinPortJervis,NewYork ,, PORTJERVIS,N.Y.,Nov....asterSealsNewYork,inpartnershipwiththeNewYorkState...OutreachatEasterSealsNewYork,sChildDevelopmentCent...dualscametotheoutreachtoreceivefreeturkeys,ham,chi...
(Date:11/24/2009)...en taking sedatives, antidepressants, benzodiazepi...HealthDay News) -- Seniors who take antidepressant...y be at increased risk for falls, a new review sho...d studies that included a total of 79,081 particip...sses of drugs: high blood pressure medicines; diur...
Breaking Medicine News(10 mins):Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2
... Influenza Campaign to Promote Annual Vaccination ...al Influenza Vaccination Week (December 8-14); Urg..., , CLEVELAND, Dec. 8 Health experts recomme...ry year. Locally, between 23,000 and 95,000 Clevel...
...s the availability,of Trade Alerts on stocks makin...e daily trading notes for free by visiting:, http:...erts include: HCP Inc. (NYSE: HCP ), Healthcare ... NHP ) and National,Health Investors Inc. (NYSE: ...
...0 on 3-Kit Packs;,Opportunity for Families to Star... Mountain View, CA (PRWEB) December 8, 2...sonal genetics, today announced it is offering a ...$70 for every additional kit., , , , ,By offering ...
...12mm AirSeal single incision laparoscopic supracer...ctomy was performed today at Mt. Auburn Hospital i... Rosenblatt performed the procedure through a sing...ot rely on traditional gaskets or valves. This pro...
...macy Outcomes Specialists collaborate to produce s...The Midwest Business Group on Health (MBGH) and Ph...tes for the second annual Pharmacy Benefits Academ...ing Network educational curriculum. The program pr...
...ells, making them easier to spot, study says , ...ance that glows and sticks to viable cancer cells,...ccessfully tested in mice, researchers report. , ...ed on the surface of some breast cancer cells. It ...
Other Medicine News:Health News:The American Lung Association of Ohio Encourages Cleveland Residents to See Themselves Among The Many 'Faces' of Influenza 2Health News:The American Lung Association of Ohio Encourages Cleveland Residents to See Themselves Among The Many 'Faces' of Influenza 3Health News:The American Lung Association of Ohio Encourages Cleveland Residents to See Themselves Among The Many 'Faces' of Influenza 4Health News:Beacon Equity Issues Technical Trade Alerts on REIT Healthcare Facilities: HCP, HR, VTR, UHT, NHP, NHI 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 3Health News:SurgiQuest Announces First Single Port Procedure for Uterus and Ovary Removal Using AirSeal(TM) Access System 2Health News:Pharmacy Benefits Academy Set for 2009 2Health News:Pharmacy Benefits Academy Set for 2009 3Health News:Glowing Substance Lights Up Cancer in Mice 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: